Agency: European Commission | Branch: FP7 | Program: CP-FP | Phase: HEALTH.2012.3.2-3 | Award Amount: 3.19M | Year: 2012
The proposed REHAB4LIFE project is intended as an advanced activity with the involvement of highly qualified medical and technical partners, as well as real patients - aimed at an extensive investigation of the issues related to long-term physical/cognitive rehabilitation processes and the identification of suitable technical solutions to efficiently support them. REHAB4LIFE will enable elderly people to enjoy high quality rehabilitation for a much longer period than the Health System can currently afford. By investigating and using standard hardware components and devices, suitable medical data processing algorithms, personalized and serious-games based rehabilitation pathways, Web2.0 social and communication tools, the project will develop an efficient, effective and engaging virtual rehabilitation environment for home-based rehabilitation. The basic project idea is inspired by existing commercial platforms, like Wii and Kinect, that allow the user acting within a virtual environment and interacting with other users, thanks to special input devices and suitable technologies able to monitor the real environment and track the users behavior. Having this in mind, REHAB4LIFE aim at the user-centred design and development of an open solution capable to: provide exercises and training - based on serious-games - within a personalized, user friendly and engaging rehabilitation program, offer a cost effective and not bulky infrastructure with sensors integrated, collect relevant physical and medical parameters for patients status inspection and relapse prevention, support off-line/on-line management and monitoring of the rehabilitation protocol, promote patients social participation and community building. In other words, REHAB4LIFE will transform the patients home in a place where physical and cognitive rehabilitation process can be performed in an intensive and engaging though properly controlled way, while promoting social inclusion and quality of life.
Agency: European Commission | Branch: H2020 | Program: IA | Phase: ICT-25-2016-2017 | Award Amount: 4.62M | Year: 2017
The global goal of the CYBERLEGs Plus Plus project is to validate the technical and economic viability of the powered robotic ortho-prosthesis developed within the framework of the FP7-ICT-CYBERLEGs project as a means to enhance/restore the mobility of transfemoral amputees and to enable them to perform locomotion tasks such as ground-level walking, walking up and down slopes, climbing/descending stairs, standing up, sitting down and turning in scenarios of real life. Restored mobility will allow amputees to perform physical activity thus counteracting physical decline and improving the overall health status and quality of life. This consortium will pursue the achievement of the global goal by addressing four specific innovation objectives. 1) Further developments of the existing CYBERLEGs hardware modules, namely the 2-degree-of-freedom active transfemoral prosthesis, the active wearable orthotic device, and the wearable sensory apparatus. 2) Further developments of the existing multi-layered CYBERLEGs control system, to enhance its reliable use in real-life scenarios. 3) Carrying out two multi-centre clinical studies, that validate the therapeutic potentialities and the economic viability of a robotic ortho-prosthesis which restores the amputees locomotion abilities in scenarios of activities of daily living. 4) Implementation of a 3-phase strategy to foster the start of the market exploitation within the time frame of the CLs\\ project. This proposal focuses on the demonstration in an operational environment (TRL=7) from both the technical and economic viability view point of a modular robotics technology for healthcare, with the ultimate goal of fostering its market exploitation. The proposals involve players from academia, end users, as well as robotics and healthcare industry. Therefore this proposal fits the specific challenge of the scope c of the call H2020-ICT-25-2016-2017.
Agency: European Commission | Branch: FP7 | Program: CP | Phase: ICT-2011.2.1 | Award Amount: 3.46M | Year: 2012
The scientific and technological global goal of the CYBERLEGs project is the development of an artificial cognitive system for dysvascular trans-femoral amputees lower-limb functional replacement and assistance in activities of daily living. CYBERLEGs will be a robotic system constituted of an active cognitive artificial leg for the functional replacement of the amputated limb and a wearable active orthosis for assisting the contralateral sound limb. CYBERLEGs will allow the amputee to walk back and forward, go up and down stairs, and move from sit-to-stand and stand-to-sit with a minimum cognitive and energetic effort. In order to achieve this ambitious goal, the control system of CYBERLEGs will be based on motor primitives as fundamental building blocks, thus endowing CYBERLEGs with semi-autonomous behaviour for planning the motion of the prosthesis joints and the assistive action of the orthosis module. CYBERLEGs will be capable of high-level cognitive skills, interfaced to the amputee through a bi-directional interaction. It will be able to understand user-motor intentions smoothly and effectively and to prevent the risk of fall for the amputee, by means of a multi-sensory fusion algorithm based on (i) the observation of the motion of the amputee body, (ii) the interaction force between CYBERLEGs and the amputee, and (iii) their force interaction with ground. Finally, CYBERLEGs will be capable of closing the loop with the amputee: the amputee will receive an efferent feedback from CYBERLEGs which will enhance the perception of CYBERLEGs as a part of his/her own body.
Agency: European Commission | Branch: H2020 | Program: RIA | Phase: PHC-19-2014 | Award Amount: 3.99M | Year: 2015
ENRICHME tackles the progressive decline of cognitive capacity in the ageing population proposing an integrated platform for Ambient Assisted Living (AAL) with a mobile service robot for long-term human monitoring and interaction, which helps the elderly to remain independent and active for longer. The system will contribute and build on recent advances in mobile service robotics and AAL, exploiting new non-invasive techniques for physiological and activity monitoring, as well as adaptive Human-Robot Interaction (HRI), to provide services in support to mental fitness and social inclusion. The system will enable caregivers and medical staff to identify evolving trends of cognitive impairments and to detect immediate emergencies. ENRICHME will use new qualitative models for rich yet compact representations of daily life activities. It will also identify humans in order to provide personalized services for elderly living with other persons. Novel context-aware HRI will provide tools for cognitive stimulation and social inclusion, which improve over time by learning from and adapting to the state of the user. A professional infrastructure of networked care will widen the social sphere of intervention in support of elderly and caregivers. ENRICHME includes multi-disciplinary research in geriatrics, gerontology and gero-technology, enabling further studies in social sciences and neuropsychology. Thanks to a modular implementation, which limits costs and allows for maximal flexibility, the system will be tested in 2 separate AAL labs and validated for 1 year in 3 different elderly housing facilities across Europe. Significant impact is expected by prolonging the independent living at home of elderly who need constant monitoring. Their quality of life will be improved by dedicated services for cognitive stimulation and social inclusion. Relevant stakeholders in the project will ensure further impact and economic exploitation of the proposed technologies for healthy ageing.
Agency: European Commission | Branch: H2020 | Program: IA | Phase: PHC-20-2014 | Award Amount: 3.18M | Year: 2015
The average human lifespan increase has significant impacts on healthcare organizations and on every aspect of citizens wellbeing. One of the main areas of intervention focuses on elderly people affected by Cognitive Impairment (CI). These people, especially when living alone, are significantly exposed to undeniable risks that can affect their health (falling, malnutrition, hygiene issues, etc.). Limitations regarding CI can also translate into social and physical limitations during daily activities (cooking, showering, ect.). The DECI project aims to improve a healthy lifestyle for elderly people effected by CI, passing through a system monitoring vital signs, treating and managing diseases and, in general, supporting the adoption of a healthy and independent lifestyle. To achieve this, the project will revolve around the definition of a business model to supply assistance services (in-house for the elderly and with a remote-based approach supporting autonomy), allowing independent living for elderly people affected by CI, granting high levels of quality of life. The proposed business model will include an up-to-date organizational model, both modular, flexible and scalable, meant for regulators and service suppliers, and the support of an IT platform based on innovative and easy-to-replicate technologies. In order to validate the business model inside real-life environments, four pilot projects will be kicked-off, by involving patients in four different countries: Israel, Italy, Spain and Sweden. Every pilot project will pass through the implementation of the organizational model and the IT solution defined as part of the DECI initiative, therefore allowing tuning of the model and of all implemented devices. Business plan and economic models (in private/ public sectors and in different countries) will be adopted in order to address cost coverage issues related to the implementation of new procedures and technological solutions inside real healthcare environments.
Agency: European Commission | Branch: H2020 | Program: CSA | Phase: ICT-03-2016 | Award Amount: 1.50M | Year: 2017
The objective of the proposed CSA is to support and complement R&I activities in Smart Systems Integration (SSI) by structuring industrial cooperation and facilitating end-user adoption for the next generations of miniaturised smart objects and systems. Previous CSAs have revealed the immense breadth of SSI in its technology demands, its application sectors, its business ramifications, its provider and user communities, and have commenced the task of joining all these aspects for concerted action. They have also developed support tools, whose proven value can continue to be instrumental in the new CSA. Building on the above and supporting the strategic activities of EPoSS, the role for inSSIght is to deepen and implant this understanding through a cadre of influential partners from SSI-related clusters, research institutes and industries who will define and encourage actions to unlock and exploit innovation opportunities, provide practice-oriented support to the SSI ecosystem, underline the vital position of SSI as a Key Enabling Technology for competitive advantage and future innovation, and give credit to their enabling role as building blocks in sectors with high potential for growth and high return on investment, such as IoT, Industry 4.0, electric mobility, automated driving, smart medical devices etc. Very practically, inSSIght organises 4 thematic conferences, two of which on MNBS, 7 demonstration sessions, 2 brokerage events, 11 expert and information workshops and 11 webinars publishes 5 White Papers on Customised Innovation Priorities leads a marketing campaign for SSI based on a trademark inSSIght addresses all 5 activities required in the scope description of ICT-03-2016b, considering them as inseparable and most efficiently tackled in a single concerted action.
Agency: European Commission | Branch: H2020 | Program: CSA | Phase: NMP-09-2014 | Award Amount: 2.00M | Year: 2015
ENATRANS main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to interact and share information, experience and advice with up-to-date information and interactive tools, but also enabling personal contacts. To be successful SMEs need to understand the requirements of the complex ecosystem made up of regulatory and reimbursement agencies, as well as the requirements of large industrial companies and clinical needs. ENATRANS will gather and provide information about approval processes, regulatory authorities and agencies, clinical and market data, and specific nanomedicine value chain analysis, relevant SME support projects and organisations. ENATRANS will convert this critical information in dedicated learning programs and tools dedicated to translation of nanomedicine. ENATRANS aims at implementing the concept of a Translation Advisory Board (TAB) as central element of the ETPN White Paper. A TAB will be set-up with senior experienced translation experts to guide R&D teams (in SMEs and research institutes) along the translation process to successfully make it to clinical trials and later to the market. Promising projects identified and supported by the TAB need access to clinical centers for first studies in patients, which are able to handle the specificity of new nanotechnology based therapeutics. In addition, financial resources are needed to go pass the regulatory and scale-up processes, which often require funding from investors and/or large companies. ENATRANS will build bridges to clinical trial centers, investors and large companies. Promising projects need guidance to successfully master privileged contacts with the medical, the business or the investment community. ENATRANS will deliver special coaching sessions prior to showcasing of promising projects. Partners in ENATRANS are VDI/VDE-IT, Nanobiotix, CEA, bioanalytik-muenster, Tel Aviv University, Fondazione Don Gnocchi, TecMinho.
Agency: European Commission | Branch: FP7 | Program: CP | Phase: ICT-2011.5.5 | Award Amount: 12.98M | Year: 2011
As we move inextricably into a digital economy there is a looming crisis for a growing number of increasingly marginalized individuals. The accessibility technologies we have are meeting the needs of only some, at high cost, and will not work with many new technologies. The path and pace of technological change predestines these approaches to fail in the very near future. At the same time the incidence of disabilities is increasing as our population ages.\nThe same technical advances however hold the potential for a radical paradigm shift in our approach to accessibility that can harness the pace of innovation and have it work for us rather than against us. An international consortium is forming to tap the unprecedented ability to pool resources and match demand with supply enabled by the Cloud to build a Global Public Inclusive Infrastructure (GPII) that can deliver accessibility to every individual where they need it, when they need it and in a way that matches their unique requirements; automatically so that they do not need to negotiate, explain, qualify or justify.\nCloud4All represents a European based effort to advance the GPII concept by pulling together a large multi-sector international community including stakeholders, industry leaders and experts in emerging technologies to thoughtfully research, design, develop and test the key software infrastructure and pilot implementations needed to explore this promising approach to digital inclusion. Cloud4All will do this by:\n-Creating/refining user profiling standards and tools capable of capturing the individual needs and preferences of the full range of users facing interface barriers\n-Creating/refining interface and materials profiling standards and tools capable of characterizing the full range of ICT/materials users need to access and the different techniques and strategies for accessing them\n-Improving mechanisms to match users and with interfaces and materials they can use or techniques or services that can make them usable\n-Creating a mechanism to allow users to locate solutions from many different sources in a single search\n-Demonstrating automatic, on-demand, matching or modification of mainstream and specialized technologiesto match each individual as they encounter them, including proof-of-concept demonstrations of this approach across a spectrum of technologies including: Computer OSs and Browsers; Web pages/Apps; Mobiles; Kiosks/Info-Transaction Machines; Installed and Virtual Assistive Technologies; Digital Televisions and Smart Homes\n-Testing of the concept with users with a wide variety and combination of physical, sensory, cognitive, language, and learning disabilities\nIf successful, this approach may give us our first chance of reaching the large group of users that do not qualify for or otherwise have not been reached by special services, but nonetheless face barriers to access that prevent them from participating in our rapidly advancing digitally enabled society.
Agency: European Commission | Branch: FP7 | Program: CSA-SA | Phase: HEALTH.2012.4.1-5 | Award Amount: 620.09K | Year: 2012
Nanotechnology applied to medical applications, Nanomedicine, is one of the most important emerging areas of health research and is understood to be the most promising out of the six KETs, for innovative devices and materials for personalised, targeted and regenerative medicine. However, due to the complexity of technologies and medical application areas Nanomedicine requires many different so far independent stakeholders from academia, industry and regulatory bodies. Due to the diversity of stakeholders the partners of this project will initiate a strong coordination and support action to build a pertinent European Nanomedicine community involving all key players necessary to define the resources, gaps and needs for development and implementation of nanomedical research into marketable innovations to be used by doctors for the benefit of patients. The implementation concepts will also target the initiation of Public Private Partnerships for the creation of novel infrastructures and innovative funding programmes. Nanomedicine research is growing fast in many countries. Therefore, the project consortium will initiate international collaborations in the Nanomedicine area, especially the coordination of international regulation of Nanomedicine products. The partners involved in the project represent major European networks combining academia, industry, clinicians and public authorities. Based on this strong partnership and after integration of further national and European initiatives the output of this support action will be a strong, established partnership of relevant stakeholders in identified key areas of Nanomedicine with new concepts for translation of nanomedical innovations into clinical practice and efficient and transparent communication channels. This will make Nanomedicine an important contributor to the future European healthcare system with a beneficial impact on improved treatment for patients and on social challenges such as ageing population.
Fondazione Don Carlo Gnocchi Onlus | Date: 2013-02-11
The present invention relates to a high voltage switch circuit, comprising an input port adapted to receive a pulse type input current and an output port, which can be used selectively to conduct an output current to a corresponding electrical load. The switch circuit comprises a buffer stage adapted to sense the input voltage at said input port and to provide a buffered voltage that follows said input voltage. The switch circuit comprises complementary switches electrically connected between said input port and said output port and a voltage level translator electrically connected with said switches, said buffer stage and a control terminal that provides a control signal. The voltage level translator provides suitable gate voltages at the gate terminals of said switches, so that the operation of these latter can be controlled by said control signal.